Alliancebernstein L.P. Ovid Therapeutics Inc. Transaction History
Alliancebernstein L.P.
- $287 Billion
- Q3 2024
A detailed history of Alliancebernstein L.P. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 47,880 shares of OVID stock, worth $36,867. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,880
Previous 47,880
-0.0%
Holding current value
$36,867
Previous $36,000
55.56%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding OVID
# of Institutions
74Shares Held
39MCall Options Held
37.4KPut Options Held
500-
Rubric Capital Management LP New York, NY5.32MShares$4.09 Million0.17% of portfolio
-
Madison Avenue Partners, LP New York, NY4.12MShares$3.17 Million0.6% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$3.07 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.97 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.14MShares$2.42 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $54.2M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...